EndPoints News – Agomab draws $100M for fibrosis pipeline, adding to drumbeat of nine-figure Series C rounds

De Tijd – 100 miljoen voor Gentse biotechbelofte die strijd aangaat met ziekte van Crohn

Fierce Biotech – Fierce Biotech’s 2022 Fierce 15

Fierce Biotech – Pfizer jumps into bed with Agomab, leading series B extension and lending support to Crohn’s program

De Tijd – Pfizer pompt miljoenen in Gentse biotechbelofte

Endpoints – The 20(+1) under 40: Your guide to the next generation of biotech leaders

InVivo – In Vivo’s 2022 Rising Leaders: Putting A Spotlight On Talent

FierceBiotech – AgomAb raises $74M to develop regenerative pathway modulators.